59 / 464
59
Programme and Exhibition Guide |
PROGRAMME
09:30-12:30
Session 1: Tumour response
09:30-10:00
Genetic biomarkers: mutations
G. Higgins (UK)
10:00-10:30
Coffee break
10:30-11:00
Genetic biomarkers: mRNA/miRNA profiles
M. De Jong (NL)
11:00-11:30
Imaging biomarkers: PET/MR
C. Gani (DE)
11:30:12:00
Imaging biomarkers: radiomics
R. Leijenaar (NL)
12:00-12:30
Circulating tumour cells and cell-free DNA/RNA
C. Decraene (FR)
12:30-13:30
Lunch
13:30-15:00
Session 2: Normal tissue
13:30-14:00
Genetic biomarkers, genomic DNA
N. Andreassen (DK)
14:00-14:30
Genetic biomarkers, mitochondrial DNA
P. Lambin (NL)
14:30-15:00
Functional biomarkers
C. Talbot (UK)
15:00-15:30
Coffee break
15:30-16:30
Session 3: Validation
15:30-16:00
Design methodology for biomarker based radiotherapy trials
S. Collette (BE)
16:00-16:30
Clinical trial example (EORTC-1219): randomised
multicenter study testing a radiosensitiser and a predictive
biomarker
B. Sørensen (DK)
16:30-17:00
Final discussion
M.C Vozenein (CH) and J.Alsner (DK)